secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuo Therapeutics, Inc. (AURX)
CIK:        0001091596
Form:       8-K
Filed at:   2022-01-04T23:59:59+00:00
Accession:  0001437749-22-000240
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuo Therapeutics modifies warrant exercise price; all warrants exercised for 6.87M shares and $1.37M
--------------------------------------------------------------------------------

- Warrant exercise price reduced from $0.40 to $0.20 per share, with exercise required by Jan 31, 2022.
- All 6,865,461 warrants exercised by Dec 30, 2021, raising $1,373,092 in gross proceeds.
- Company issued 6.87M shares of common stock in exempt private placement under Section 4(a)(2) and 3(a)(9).
- Warrants were originally issued in October 2020 recapitalization and for services to executives including CEO David Jorden.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1091596/000143774922000240/0001437749-22-000240-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1091596/000143774922000240/aurx20220103_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-000240

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer